Related Experiment Videos
[Cycloplegia with cyclopentolate for testing-refraction of children (author's transl)]
Insights
Atropine is more effective for correcting hypermetropia in young strabismic children (1.5-6 years). For older children (6-11 years), cyclopentolate offers a better balance of efficacy and duration.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Optometry
Background:
- Accurate refractive error assessment is crucial in pediatric strabismus management.
- Cycloplegic agents are essential for overcoming accommodation during refraction.
- Comparing the efficacy of different cycloplegic agents is important for optimizing treatment.
Purpose of the Study:
- To compare the cycloplegic effects of 1% cyclopentolate, atropine, and homatropine.
- To determine the most effective cycloplegic agent for different age groups of strabismic children.
- To guide the selection of cycloplegic agents for accurate hypermetropia correction in pediatric strabismus.
Main Methods:
- A comparative study utilizing Lindner's method of retinoscopy.
- Evaluation of cycloplegic effects in strabismic patients aged 1.5 to 11 years.
- Assessment of hypermetropic refraction under the influence of atropine, cyclopentolate, and homatropine.
Main Results:
- Atropine revealed higher hypermetropic refraction (average 0.6 dpt) in 53% of strabismic patients aged 1.5 to 6 years.
- Cyclopentolate was more effective than homatropine in 27% of children aged 6 to 11 years (average 0.5 dpt).
Conclusions:
- Atropine is recommended for children up to 6 years with convergent squint to ensure full hypermetropia correction.
- Cyclopentolate is preferable for other cases due to its rapid, potent, and short-duration cycloplegic effect.
- The choice of cycloplegic agent should be tailored to the patient's age and specific refractive needs in strabismus.
Abstract:
A comparative study of the cycloplegic effect of 1% cyclopentolate and atropine or homatropine was done by means of Lindner's method of retinoscopy. In 53% of 1.5- to 6-year-old strabismic patients the hypermetropic refraction was higher (average 0.6 dpt) under the use of atropine, and in 27% of 6- to 11-year-old children cyclopentolate was more effective than homatropine (average 0.5 dpt). Therefore, atropine should be used for children with convergent squint up to 6 years, in order to get full correction of hypermetropia. In other cases cyclopentolate is preferable because of its rapid and strong efficiency of brief duration.